What is the price target for SOL stock?
5 analysts have analysed SOL and the average price target is 7.14 USD. This implies a price increase of 268.04% is expected in the next year compared to the current price of 1.94.
EMEREN GROUP LTD (SOL) Forecast, Price Target & Analyst Ratings
NYSE:SOL • US75971T3014
Current stock price
1.94 USD
+0.01 (+0.52%)
At close:
1.94 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EMEREN GROUP LTD (SOL).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 11, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.05
- Revenue Estimate
- 28.43M
Price Target Details & History
Consensus Price Target and Range
Mean target
$7.14
Upside
+ 268.04%
From current price of $1.94 to mean target of $7.14, Based on 5 analyst forecasts
Low
$7.07
Median
$7.14
High
$7.35
Price Target Revisions
1 Month
0.00%
3 Months
55.56%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for SOL. The average price target is 7.14 USD. This implies a price increase of 268.04% is expected in the next year compared to the current price of 1.94.
The average price target has been revised upward by 55.56% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
SOL was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SOL.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed SOL. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-03-17 | Roth MKM | Maintains | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-16 | BWS Financial | Maintains | Sell -> Sell |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-21 | Roth MKM | Maintains | Buy -> Buy |
| 2024-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | Northland Capital Markets | Downgrade | Market Perform -> Underperform |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-22 | Roth MKM | Maintains | Buy -> Buy |
| 2023-11-22 | Northland Capital Markets | Downgrade | Outperform -> Market Perform |
| 2023-11-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-03 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-09-12 | Roth MKM | Maintains | Buy -> Buy |
| 2023-09-01 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2023-09-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-10-13 | Raymond James | Maintains | Strong Buy |
| 2022-09-13 | Northland Capital Markets | Initiate | Outperform |
| 2022-07-12 | Raymond James | Maintains | Strong Buy |
| 2022-01-05 | Roth Capital | Upgrade | Neutral -> Buy |
| 2022-01-04 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2021-10-05 | Raymond James | Maintains | Outperform |
| 2021-09-01 | Roth Capital | Maintains | Neutral |
| 2021-05-26 | Roth Capital | Maintains | Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 11, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.05
- Revenue Estimate
- 28.43M
- Revenue Q2Q
- -17.71%
- EPS Q2Q
- 121.96%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
SOL is expected to report earnings on 3/11/2026. The consensus EPS estimate for the next earnings is 0.05 USD and the consensus revenue estimate is 28.43M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 61.3M -23.09% | 105.642M 72.34% | 92.067M -12.85% | 84.944M -7.74% | 123.48M 45.37% | |
| EBITDA YoY % growth | 4.2M -80.00% | 860K -79.52% | 6.411M 645.47% | 16.36M 155.19% | 30.336M 85.43% | |
| EBIT YoY % growth | -2.6M -118.31% | -6.97M -168.08% | -504K 92.77% | 2.62M 619.84% | 14.272M 444.73% | |
| Operating Margin | -4.24% | -6.60% | -0.55% | 3.08% | 11.56% | |
| EPS YoY % growth | 0.07 -22.22% | -0.18 -357.14% | -0.21 -16.67% | 0.04 116.83% | 0.21 485.71% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.05 121.96% | -0.05 -268.33% | -0.02 -103.61% | 0.02 -20.00% | 0.02 -60.00% |
| Revenue Q2Q % growth | 28.43M -17.71% | 17.473M 114.29% | 23.23M 80.34% | 30.603M 95.66% | 31.815M 11.91% |
| EBITDA Q2Q % growth | 6.77M 167.91% | 2.02M 201.51% | 4.04M 299.80% | 6.565M -50.78% | 7.171M 5.92% |
| EBIT Q2Q % growth | 4.902M 211.71% | -2.727M 33.46% | -808K 87.55% | 1.515M -77.79% | 1.818M -62.91% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
EMEREN GROUP LTD / SOL Forecast FAQ
When does EMEREN GROUP LTD (SOL) report earnings?
EMEREN GROUP LTD (SOL) will report earnings on 2026-03-11, after the market close.
What are the consensus estimates for EMEREN GROUP LTD (SOL) next earnings?
The consensus EPS estimate for the next earnings of EMEREN GROUP LTD (SOL) is 0.05 USD and the consensus revenue estimate is 28.43M USD.
What is the consensus rating for SOL stock?
The consensus rating for EMEREN GROUP LTD (SOL) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.